Home › NCT06831929
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Human Papillomavirus Ends Here: A Multilevel Intervention to Increase Uptake of the HPV Vaccine Among Adolescents
Who can join
Ages 10 to 12 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: • Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine Exclusion Criteria: • Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.
About the study
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
What is being tested
- Intervention Arm (behavioral)
Sponsor: University of California, Davis · Participants: 2,232 · Started: Feb 28, 2025
Contact the study team
- Julie Dang, PhD, MPH · Phone: 9167345222
Official record on ClinicalTrials.gov — NCT06831929
Locations in the U.S.
| California | University of California Davis Health, Sacramento |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.